Milixim-O 100mg/100mg Tablet DT is a fixed-dose combination of cefixime and ofloxacin, used in the treatment of mild to moderate infections caused by susceptible Gram-positive and Gram-negative bacteria. This oral antibiotic is specifically designed for patients with a body mass index (BMI) of 30 kg/m² or greater, who have mild to moderate infections such as uncomplicated urinary tract infections (UTIs), community-acquired pneumonia, and acute exacerbations of chronic bronchitis. The cefixime component has a broad spectrum of activity against Gram-positive and Gram-negative bacteria, including Escherichia coli, Haemophilus influenzae, Streptococcus pneumoniae, and Klebsiella pneumoniae. The ofloxacin component has potent antimicrobial activity against Gram-negative bacteria, including Pseudomonas aeruginosa. Milixim-O 100mg/100mg Tablet DT is administered twice daily for a minimum of 7 days, and is contraindicated in patients with a history of hypersensitivity to either cefixime or ofloxacin.